322 related articles for article (PubMed ID: 28841835)
1. Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes.
Przytycki PF; Singh M
Genome Med; 2017 Aug; 9(1):79. PubMed ID: 28841835
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
3. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
4. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
5. Identifying cancer driver genes in tumor genome sequencing studies.
Youn A; Simon R
Bioinformatics; 2011 Jan; 27(2):175-81. PubMed ID: 21169372
[TBL] [Abstract][Full Text] [Related]
6. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
[TBL] [Abstract][Full Text] [Related]
7. Detecting statistical interaction between somatic mutational events and germline variation from next-generation sequence data.
Hu H; Huff CD
Pac Symp Biocomput; 2014; ():51-62. PubMed ID: 24297533
[TBL] [Abstract][Full Text] [Related]
8. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
9. The emerging significance of secondary germline testing in cancer genomics.
Mandelker D; Zhang L
J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
[TBL] [Abstract][Full Text] [Related]
10. Driver gene mutations based clustering of tumors: methods and applications.
Zhang W; Flemington EK; Zhang K
Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
[TBL] [Abstract][Full Text] [Related]
11. Joint genotype inference with germline and somatic mutations.
Bareke E; Saillour V; Spinella JF; Vidal R; Healy J; Sinnett D; Csűrös M
BMC Bioinformatics; 2013; 14 Suppl 5(Suppl 5):S3. PubMed ID: 23734724
[TBL] [Abstract][Full Text] [Related]
12. [Whole exome sequencing in oncology].
Suspitsyn EN; Sokolenko AP; Imyanitov EN
Vopr Onkol; 2016; 62(6):713-718. PubMed ID: 30695557
[TBL] [Abstract][Full Text] [Related]
13. Germline fitness-based scoring of cancer mutations.
Fischer A; Greenman C; Mustonen V
Genetics; 2011 Jun; 188(2):383-93. PubMed ID: 21441214
[TBL] [Abstract][Full Text] [Related]
14. Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers.
Guo J; Zhou Y; Xu C; Chen Q; Sztupinszki Z; Börcsök J; Xu C; Ye F; Tang W; Kang J; Yang L; Zhong J; Zhong T; Hu T; Yu R; Szallasi Z; Deng X; Li Q
Cancer Res; 2021 Aug; 81(16):4205-4217. PubMed ID: 34215622
[TBL] [Abstract][Full Text] [Related]
15. ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.
Kalatskaya I; Trinh QM; Spears M; McPherson JD; Bartlett JMS; Stein L
Genome Med; 2017 Jun; 9(1):59. PubMed ID: 28659176
[TBL] [Abstract][Full Text] [Related]
16. Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.
Han H; Lehner B; Lee I
Methods Mol Biol; 2019; 1907():37-50. PubMed ID: 30542989
[TBL] [Abstract][Full Text] [Related]
17. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
Tan H; Zhou X
Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of germline and somatic microlesion mutational spectra in 17 human tumor suppressor genes.
Ivanov D; Hamby SE; Stenson PD; Phillips AD; Kehrer-Sawatzki H; Cooper DN; Chuzhanova N
Hum Mutat; 2011 Jun; 32(6):620-32. PubMed ID: 21432943
[TBL] [Abstract][Full Text] [Related]
19. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
[TBL] [Abstract][Full Text] [Related]
20. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
